AbbVie (ABBV) Other Non-Current Liabilities (2012 - 2026)
AbbVie (ABBV) recorded Other Non-Current Liabilities of $34.6 billion in Q2 2026, up 8.0% from $32.04 billion a year earlier and up 1.4% from the prior quarter.
AbbVie (ABBV) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025, AbbVie reported Other Non-Current Liabilities of $32.57 billion, up 8.1% from FY2024.
- Annual Other Non-Current Liabilities has a five-year compound annual growth rate of 3.4% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Liabilities came in at $30.13 billion in FY2024 (-6.8%), $32.33 billion in FY2023 (+5.5%), $30.66 billion in FY2022 (+6.8%) and $28.7 billion in FY2021 (+4.0%).
- The Q2 2026 figure is the highest quarterly Other Non-Current Liabilities in data going back to Q4 2012.
- On a year-over-year basis, Other Non-Current Liabilities has increased for three consecutive quarters, with growth averaging 1.6% over the last eight quarters.
- Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 24.4% in Q3 2021, against a decline of 6.8% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $34.11 billion (Q1 2026), $32.57 billion (Q4 2025) and $31.66 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 128.38 Bn | 100.39 Bn | 2.84 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.60 Bn |
| Mar 31, 2026 | 34.11 Bn |
| Dec 31, 2025 | 32.57 Bn |
| Sep 30, 2025 | 31.66 Bn |
| Jun 30, 2025 | 32.04 Bn |
| Mar 31, 2025 | 31.19 Bn |
| Dec 31, 2024 | 30.13 Bn |
| Sep 30, 2024 | 33.03 Bn |
| Jun 30, 2024 | 32.43 Bn |
| Mar 31, 2024 | 32.78 Bn |
| Dec 31, 2023 | 32.33 Bn |
| Sep 30, 2023 | 31.64 Bn |
| Jun 30, 2023 | 32.29 Bn |
| Mar 31, 2023 | 32.25 Bn |
| Dec 31, 2022 | 30.66 Bn |
| Sep 30, 2022 | 30.22 Bn |
| Jun 30, 2022 | 30.77 Bn |
| Mar 31, 2022 | 28.02 Bn |
| Dec 31, 2021 | 28.70 Bn |
| Sep 30, 2021 | 29.10 Bn |
AbbVie Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ABBV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();